A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

(Nanowerk Spotlight) Cancer treatments have traditionally involved a difficult balance between effectiveness and side effects. For skin cancers, this challenge is particularly pronounced. Researchers ...

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease. Current diagnostic methods, such as prostate-specific antigen (PSA) testing and ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

Discover how urinary microRNA biomarkers can non-invasively identify aggressive bladder cancer subtypes. Read more on this ...

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

A team of researchers at the Georgetown University Lombardi Comprehensive Cancer Center published new research exploring causes and potential treatment methods for pancreatic ...

PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76. (HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is ...

This study validated PROSTOX as predicting radiotherapy-induced genitourinary toxicity, which can be differentiated into acute and chronic with mirSNP-based signatures, in patients with prostate ...